Operation Nasal Vaccine-Lightning speed to counter COVID-19
- PMID: 35862488
- DOI: 10.1126/sciimmunol.add9947
Operation Nasal Vaccine-Lightning speed to counter COVID-19
Abstract
Given the poor ability of intramuscular mRNA COVID-19 vaccines to induce robust immunity in the respiratory mucosa, a push for a nasal vaccine strategy is needed.
Comment on
-
Respiratory mucosal immunity against SARS-CoV-2 after mRNA vaccination.Sci Immunol. 2022 Oct 28;7(76):eadd4853. doi: 10.1126/sciimmunol.add4853. Epub 2022 Oct 21. Sci Immunol. 2022. PMID: 35857583 Free PMC article.
Similar articles
-
Politicizing public health: the powder keg of rushing COVID-19 vaccines.Hum Vaccin Immunother. 2021 Jun 3;17(6):1662-1663. doi: 10.1080/21645515.2020.1846400. Epub 2020 Dec 17. Hum Vaccin Immunother. 2021. PMID: 33327848 Free PMC article.
-
COVID-19 Vaccines May Not Prevent Nasal SARS-CoV-2 Infection and Asymptomatic Transmission.Otolaryngol Head Neck Surg. 2021 Feb;164(2):305-307. doi: 10.1177/0194599820982633. Epub 2020 Dec 15. Otolaryngol Head Neck Surg. 2021. PMID: 33320052
-
Importance of nasal secretions in the evaluation of mucosal immunity elicited by mRNA BNT162b2 COVID-19 Vaccine.EBioMedicine. 2022 May;79:104006. doi: 10.1016/j.ebiom.2022.104006. Epub 2022 Apr 14. EBioMedicine. 2022. PMID: 35430452 Free PMC article. No abstract available.
-
COVID-19 vaccines: concerns beyond protective efficacy and safety.Expert Rev Vaccines. 2021 Aug;20(8):1013-1025. doi: 10.1080/14760584.2021.1949293. Epub 2021 Jul 5. Expert Rev Vaccines. 2021. PMID: 34180347 Review.
-
SARS-CoV-2 vaccine candidates in rapid development.Hum Vaccin Immunother. 2021 Mar 4;17(3):644-653. doi: 10.1080/21645515.2020.1804777. Epub 2020 Oct 29. Hum Vaccin Immunother. 2021. PMID: 33121319 Free PMC article. Review.
Cited by
-
Reaching the Final Endgame for Constant Waves of COVID-19.Viruses. 2022 Nov 25;14(12):2637. doi: 10.3390/v14122637. Viruses. 2022. PMID: 36560641 Free PMC article. Review.
-
Maintaining Warp Speed: Policy Requirements for a Just-in-Time, Capability-Based, Scalable Medical Countermeasure Research and Development Enterprise.Health Secur. 2023 Jul-Aug;21(4):272-279. doi: 10.1089/hs.2022.0134. Epub 2023 May 18. Health Secur. 2023. PMID: 37200519 Free PMC article. No abstract available.
-
Tissue-Resident Memory T Cell: Ontogenetic Cellular Mechanism and Clinical Translation.Clin Exp Immunol. 2023 Dec 13;214(3):249-259. doi: 10.1093/cei/uxad090. Clin Exp Immunol. 2023. PMID: 37586053 Free PMC article. Review.
-
Recent review of COVID-19 management: diagnosis, treatment and vaccination.Pharmacol Rep. 2022 Dec;74(6):1120-1148. doi: 10.1007/s43440-022-00425-5. Epub 2022 Oct 10. Pharmacol Rep. 2022. PMID: 36214969 Free PMC article. Review.
-
A novel mucosal bivalent vaccine of EV-A71/EV-D68 adjuvanted with polysaccharides from Ganoderma lucidum protects mice against EV-A71 and EV-D68 lethal challenge.J Biomed Sci. 2023 Dec 18;30(1):96. doi: 10.1186/s12929-023-00987-3. J Biomed Sci. 2023. PMID: 38110940 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical